Colasito, Jarade .

HRN: 28-64-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2026
CEFUROXIME 750MG (VIAL)
04/03/2026
04/10/2026
IV
230mg
Q8hours
Acute Bacterial Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: